The current valuation score of MediciNova Inc is 7.27, ranking 245 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.95, which is -17.65% below the recent high of -4.90 and -112.04% above the recent low of -12.61.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.